CCND1 and acute promyelocytic leukemia: Interestingly, UBE2D3 was found upregulated in ATRA-treated NB4 acute promyelocytic leukemia cells, leading to UBE2D3-mediated degradation of cyclin D1 and cell cycle arrest (11).